VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1
+$2.17M
2
+$2.09M
3
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1
+$2.5M
2
+$2.43M
3
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPB
301
Upstream Bio Inc
UPB
$412M
$266K 0.07%
9,801
-42
NTLA icon
302
Intellia Therapeutics
NTLA
$1.77B
$265K 0.07%
29,493
+15,866
SMMT icon
303
Summit Therapeutics
SMMT
$12.1B
$265K 0.07%
15,141
+9,497
NRIX icon
304
Nurix Therapeutics
NRIX
$1.63B
$265K 0.07%
13,949
+4,435
INBX icon
305
Inhibrx
INBX
$1.11B
$264K 0.07%
+3,343
CLDX icon
306
Celldex Therapeutics
CLDX
$2.01B
$263K 0.07%
9,671
+4,079
NGNE icon
307
Neurogene
NGNE
$316M
$262K 0.07%
12,716
+7,138
MLYS icon
308
Mineralys Therapeutics
MLYS
$2.3B
$262K 0.07%
7,209
-417
STOK icon
309
Stoke Therapeutics
STOK
$2.2B
$261K 0.07%
8,214
-1,413
BHVN icon
310
Biohaven
BHVN
$1.54B
$260K 0.07%
23,072
+15,773
APGE icon
311
Apogee Therapeutics
APGE
$4.82B
$260K 0.07%
3,451
+733
DNTH icon
312
Dianthus Therapeutics
DNTH
$2.4B
$260K 0.07%
6,315
+416
SYRE icon
313
Spyre Therapeutics
SYRE
$3.35B
$259K 0.07%
7,913
+1,488
GHRS icon
314
GH Research
GHRS
$980M
$259K 0.07%
20,408
+11,539
VRDN icon
315
Viridian Therapeutics
VRDN
$2.85B
$256K 0.07%
8,233
+971
IMVT icon
316
Immunovant
IMVT
$5.72B
$256K 0.07%
10,069
+2,931
SION
317
Sionna Therapeutics
SION
$1.54B
$256K 0.07%
6,220
-478
GLUE icon
318
Monte Rosa Therapeutics
GLUE
$1.4B
$256K 0.07%
16,310
-6,818
NUVL icon
319
Nuvalent
NUVL
$7.85B
$255K 0.07%
2,538
+1,077
REPL icon
320
Replimune Group
REPL
$595M
$254K 0.07%
26,133
+14,622
BCYC
321
Bicycle Therapeutics
BCYC
$393M
$253K 0.07%
35,709
+22,615
TSHA icon
322
Taysha Gene Therapies
TSHA
$1.25B
$253K 0.07%
45,946
+3,008
VKTX icon
323
Viking Therapeutics
VKTX
$3.89B
$252K 0.07%
7,174
+3,192
CELC icon
324
Celcuity
CELC
$5.02B
$252K 0.07%
2,528
-6,531
TNGX icon
325
Tango Therapeutics
TNGX
$1.57B
$252K 0.07%
28,452
+5,920
11 12
13
14 15